Showing results (151-160 of 253) with videos related to
Sort By:
Pageof 26
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|February 23, 2010
2009 Santa Fe Bone symposiumE Michael Lewiecki, John P Bilezikian, Andrew J Laster, et al.JBMR Plus|April 8, 2020
Estimation of Long-Term Efficacy of Denosumab Treatment in Postmenopausal Women With Osteoporosis: A FRAX- and Virtual Twin-Based Post Hoc Analysis From the FREEDOM and FREEDOM Extension TrialsEthel Siris, Michele McDermott, Nicola Pannacciulli, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 14, 2005
Recalculation of the NHANES database SD improves T-score agreement and reduces osteoporosis prevalenceNeil Binkley, Gary M Kiebzak, E Michael Lewiecki, et al.Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|February 11, 2017
Proceedings of the 2016 Santa Fe Bone Symposium: New Concepts in the Management of Osteoporosis and Metabolic Bone DiseasesE Michael Lewiecki, John P Bilezikian, Susan V Bukata, et al.The American Journal of Geriatric Pharmacotherapy|November 1, 2005
A randomized, placebo-controlled, 6-month study of once-weekly alendronate oral solution for postmenopausal osteoporosisByron Cryer, Neil Binkley, Christine Simonelli, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 10, 2025
Bone turnover markers predict changes in bone mineral density in men treated with abaloparatide: results from the abaloparatide for the treatment of men with osteoporosis (ATOM) studyRichard Eastell, Jacques P Brown, Robert A Adler, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 21, 2012
Denosumab reduces the risk of osteoporotic fractures in postmenopausal women, particularly in those with moderate to high fracture risk as assessed with FRAXEugene V McCloskey, Helena Johansson, Anders Oden, et al.Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|January 12, 2016
Proceedings of the 2015 Santa Fe Bone Symposium: Clinical Applications of Scientific Advances in Osteoporosis and Metabolic Bone DiseaseE Michael Lewiecki, Roland Baron, John P Bilezikian, et al.The Journal of Clinical Endocrinology and Metabolism|June 23, 2018
A Phase III Randomized Placebo-Controlled Trial to Evaluate Efficacy and Safety of Romosozumab in Men With OsteoporosisE Michael Lewiecki, Tomasz Blicharski, Stefan Goemaere, et al.The Journal of Clinical Endocrinology and Metabolism|August 30, 2007
Effects of atorvastatin on bone in postmenopausal women with dyslipidemia: a double-blind, placebo-controlled, dose-ranging trialHenry G Bone, Douglas P Kiel, Robert S Lindsay, et al.Pageof 26